This site is intended for health professionals only

The role of docetaxel (Taxotere) in head and neck squamous cell carcinoma (HNSCC) management

teaser

In the past 20 years concurrent chemoradiotherapy has gained popularity over induction chemotherapy (ICT). Positive trial results with docetaxel prompt the conclusion that ICT must be revisited.






Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine

x